Rather than VEGF-A blockage/absence itself, this could occur because upon VEGF-A inhibition and subsequent VEGF-A-driven angiogenesis impairment, the tumour microenvironment where cancer cells grow likely becomes increasingly hypoxic/acidic, conditions that stimulate the VM-driven tumour vascularisation. This evidence concerns the gene VEGFA and cancer.